DarioHealth Corp. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
DarioHealth Corp. (DRIO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$700.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2024-11-07
- DarioHealth Corp. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-09-30 was -$700.00K.
- DarioHealth Corp. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-03-31 was -$9.16M.
- DarioHealth Corp. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2018-03-31 was -$1.00K, a 100.08% decline year-over-year.
- DarioHealth Corp. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-09-30 was -$1.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$700.00K 10-Q · filed 2024-11-07 | ||||||
| 2024-03-31 | -$9.16M 10-Q · filed 2024-08-08 | ||||||
| 2018-03-31 | -$1.00K 10-Q · filed 2018-05-15 | ||||||
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | -$26.00K derived: sum of 2 quarters · filed 2018-03-19 | $1.17M 10-Q · filed 2018-03-19 | -$7.49M 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-19 | $1.17M 10-Q · filed 2018-03-19 | -$7.49M 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | $1.20M 10-Q · filed 2018-03-19 | -$7.46M 10-Q · filed 2017-05-15 | |||||
| 2015-03-31 | -$150.00K 10-Q · filed 2015-05-14 | ||||||
| 2013-09-30 | $3.99M 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $1.66M 10-Q · filed 2013-08-14 | $3.80M derived: sum of 2 quarters · filed 2013-08-14 | |||||
| 2013-03-31 | $2.14M 10-Q · filed 2013-08-14 | ||||||
| 2012-12-31 | $1.61M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |